statistiche ricercatore

Continente	#
AS - Asia	489
NA - Nord America	392
EU - Europa	325
SA - Sud America	57
AF - Africa	27
Continente sconosciuto - Info sul continente non disponibili	1
OC - Oceania	1
Totale	1.292

Nazione	#
US - Stati Uniti d'America	376
SG - Singapore	203
RU - Federazione Russa	154
VN - Vietnam	105
CN - Cina	93
IT - Italia	59
BR - Brasile	48
DE - Germania	33
HK - Hong Kong	31
FR - Francia	17
FI - Finlandia	13
CA - Canada	10
GB - Regno Unito	10
NL - Olanda	10
IN - India	9
ZA - Sudafrica	9
BD - Bangladesh	8
JP - Giappone	8
CI - Costa d'Avorio	7
KR - Corea	7
AR - Argentina	6
PK - Pakistan	6
PL - Polonia	6
IE - Irlanda	5
PH - Filippine	5
AT - Austria	4
TR - Turchia	4
IQ - Iraq	3
LV - Lettonia	3
MA - Marocco	3
MX - Messico	3
CR - Costa Rica	2
EG - Egitto	2
SE - Svezia	2
UZ - Uzbekistan	2
AE - Emirati Arabi Uniti	1
AO - Angola	1
AU - Australia	1
BE - Belgio	1
BN - Brunei Darussalam	1
CG - Congo	1
CH - Svizzera	1
CL - Cile	1
CW - ???statistics.table.value.countryCode.CW???	1
CZ - Repubblica Ceca	1
DO - Repubblica Dominicana	1
EC - Ecuador	1
ES - Italia	1
ET - Etiopia	1
GA - Gabon	1
GR - Grecia	1
HR - Croazia	1
ID - Indonesia	1
KE - Kenya	1
KZ - Kazakistan	1
MZ - Mozambico	1
PT - Portogallo	1
PY - Paraguay	1
RO - Romania	1
TH - Thailandia	1
UA - Ucraina	1
Totale	1.292

Nome	#
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data	193
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort	178
A third-line sorafenib aftrer sequential therapy with sunitinib and mTOR inhibitors in methastatic renal cell carcinoma	162
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort	159
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination	152
A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study	124
Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study	120
Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice	110
HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome	109
Totale	1.307

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	32	0	0	0	0	0	1	0	0	3	3	12	13
2022/2023	59	5	2	0	6	10	8	1	4	6	11	6	0
2023/2024	56	0	7	8	3	6	5	0	12	2	3	6	4
2024/2025	369	9	4	1	11	22	20	29	23	23	36	155	36
2025/2026	718	75	59	72	60	104	35	111	28	85	57	22	10
2026/2027	31	31	0	0	0	0	0	0	0	0	0	0	0
Totale													1.307